AbCellera Biologics Inc. (8QQ.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:03AM CEST. Market open.
| Previous close | 3.5570 |
| Open | 3.5010 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 3.5010 - 3.5010 |
| 52-week range | 3.3680 - 7.2000 |
| Volume | |
| Avg. volume | 209 |
| Market cap | 1.029B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4800 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 45.40 |
ZacksCytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
VANCOUVER, British Columbia, May 01, 2024--AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
ZacksAnalysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
AbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.